Methods and compositions for noninvasive dose-to-effect...

Details Methods and compositions for noninvasive dose-to-effect... Methods and compositions for noninvasive dose-to-effect...

A - Human Necessities

61

K

167/165, 167/168

A61K 9/00 (2006.01) A23G 3/00 (2006.01)

Patent

CA 1339080

The present invention is directed to methods and compositions for noninvasively administering drugs in a dose-to-effect manner to produce a cardiovascular or renal vascular activity. A cardiovascular or renal vascular drug, which is capable of absorption through mucosal tissues of the mouth, pharnyx, and esophagus is incorporated into a matrix which is in the form of a lollipop. A patient is put at ease when given the lollipop, and the drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and remove the lollipop when it has had a desired effect on the patient. A lollipop into which a cardiovascular or renal vascular drug has been dispersed is particularly useful for achieving rapid vasodilating, calcium channel blocking, beta-blocking, seritonin receptor blocking, angina blocking, anti-hypertensive, and cardiac stimulating effects and for controlling urine output.

610327

Affiliated with

Also associated with

Rating

Methods and compositions for noninvasive dose-to-effect... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for noninvasive dose-to-effect..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for noninvasive dose-to-effect... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1235940